Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
14.34
+0.15 (1.06%)
At close: Dec 20, 2024, 4:00 PM
14.33
-0.01 (-0.07%)
After-hours: Dec 20, 2024, 6:29 PM EST
Progyny Market Cap
Progyny has a market cap or net worth of $1.22 billion as of December 20, 2024. Its market cap has decreased by -64.91% in one year.
Market Cap
1.22B
Enterprise Value
1.00B
1-Year Change
-64.91%
Ranking
Category
Stock Price
$14.34
Market Cap Chart
Since October 25, 2019, Progyny's market cap has decreased from $1.31B to $1.22B, a decrease of -6.78%. That is a compound annual growth rate of -1.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.22B | -65.73% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | 2.31B | 76.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.23B |
| STAAR Surgical Company | 1.23B |
| Pediatrix Medical Group | 1.22B |
| Harrow | 1.21B |
| Myriad Genetics | 1.21B |
| BioLife Solutions | 1.19B |
| Artivion | 1.18B |
| Embecta | 1.16B |